ISA Pharmaceuticals is a clinical stage company developing novel therapeutic vaccines for cancer and infectious diseases. ISA exploits its proprietary SLP® technology to achieve therapeutic effects in a number of indications. The most advanced product under development is a therapeutic HPV-SLP® vaccine for the treatment of patients suffering from Human Papilloma Virus type 16 (HPV16) associated (pre-) malignant disorders.